TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel October 17, 1980
TCL Archive Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting. December 7, 2007